Anti-metastasis therapy: MiRNA-9600 increases the expression of metastasis suppressor Sprouty1 and inhibits proliferation, invasion and metastasis of cancer cells via down regulation of its target gene, 8/February/2017, 10.23 pm

Natural product-based Lifespan extension therapy: Arecoline/Areca nut extract prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 8/February/2017, 9.25 pm
February 8, 2017
Molecular therapy for Myocardial Infarction: Long ncRNA CUDR (Cancer up regulated drug resistant) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up-regulation of PNUTS, 8/February/2017, 10.54 pm
February 8, 2017
Show all

Research findings to Therapeutic opportunity: 

The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of metastasis suppressor Sprouty1.

price-2

Thereby, it may inhibit proliferation, migration, invasion,  and metastasis of cancer cells. Thus, pharmacological formulations encompassing “MiRNA-9600 activators” may be used to inhibit the progression of invasive tumors.


Details of the research findings

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed information: How MiRNA-9600  increases the expression of metastasis suppressor Sprouty1

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $2

For purchase and payment details, you may reach us at info@genomediscovery.org


References

CitationBoominathan, L., Anti-metastasis therapy: MiRNA-9600 increases the expression of metastasis suppressor Sprouty1 and inhibits proliferation, invasion and metastasis of cancer cells via down regulation of its target gene, 8/February/2017, 10.23 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.